RECRUITING

Evaluation of Grief Therapy Approaches for Bereaved Parents

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to compare three types of support programs for parents who have lost a child. The study will see how these support programs affect participants' grief and depression symptoms. The three support programs are called Meaning-Centered Grief Therapy, Supportive Counseling, and Enhanced Usual Care.

Official Title

Meaning-Centered Grief Therapy for Parents Bereaved by Cancer: A Multisite Randomized Controlled Trial

Quick Facts

Study Start:2022-03-31
Study Completion:2026-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05142605

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * A biological, adoptive, step-parent or legal guardian from across the United States who lost a child diagnosed with cancer as indicated by self-report
  2. * Age 18 or older as indicated by self-report
  3. * Experienced the loss of a child diagnosed with cancer at least 6 months prior to enrollment as indicated by self-report
  4. * Elevated prolonged grief (PG) symptoms (PG-13-R scores of 30 or above)
  5. * Resides in a state in which a study clinical supervisor is licensed to permit telepsychology practice or otherwise able to comply with current telehealth regulations as indicated by self-report
  6. * English-speaking as per the language assessment items below and willing to receive the intervention in English.
  7. * What is the participant's preferred language?
  8. * How well does the participant speak English?
  9. * Very well (PARTICIPANT IS ELIGIBLE)
  10. * Well (PARTICIPANT is NOT ELIGIBLE)
  11. * Not well (PARTICIPANT is NOT ELIGIBLE)
  12. * Not at all (PARTICIPANT is NOT ELIGIBLE)
  1. * Significant psychiatric disturbance sufficient, in the investigator/study staff's judgment, to preclude completion of the assessment measures, interview or informed consent
  2. * Inability to access a functional device for videoconferencing and declines offer to use a study loaner device as indicated by self-report
  3. * Prisoners
  4. * Participants unable to consent

Contacts and Locations

Study Contact

Wendy G. Lichtenthal, PhD
CONTACT
305-243-8983
wendy.lichtenthal@miami.edu

Principal Investigator

Wendy G. Lichtenthal, PhD
PRINCIPAL_INVESTIGATOR
University of Miami

Study Locations (Sites)

University of Miami
Miami, Florida, 33136
United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065
United States
Children's Hospital of Philadelphia (Data Collection Only)
Philadelphia, Pennsylvania, 19104
United States
St Jude's Children's Hospital (Data collection only)
Memphis, Tennessee, 38105
United States

Collaborators and Investigators

Sponsor: University of Miami

  • Wendy G. Lichtenthal, PhD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-31
Study Completion Date2026-05-31

Study Record Updates

Study Start Date2022-03-31
Study Completion Date2026-05-31

Terms related to this study

Keywords Provided by Researchers

  • Parental bereavement
  • Parents
  • Elevated prolonged grief symptoms

Additional Relevant MeSH Terms

  • Grief
  • Bereavement
  • Cancer